Recordati Pharma GmbH
With approximately 200 employees, Recordati Pharma GmbH - formerly Merckle Recordati GmbH - distributes drugs and medical products on the German market. In 2018, the company generated gross sales of more than 137 million euros.
The company focuses on products for treating musculoskeletal, gastroenterological and urological disorders, as well as high blood pressure. The range of over-the-counter pharmacy products includes well-known brands such as Dolobene® Ibu, Mirfulan®, Osteoplus®, Rhinopront®, JHP® Rödler and Laxbene®.
The company was founded in 2005 through the acquisition of the Original Products division of the former Merckle GmbH and is the German subsidiary of the Italian Recordati S.p.A. group. Based in Milan, the stock market-oriented group of companies has its own research and development facilities and is represented in all major countries of the world. In total, the company employs approximately 4,000 people and has a turnover of around 1,352 million euros.
